Titan Pharmaceuticals
TTNP
$6.88
Share price
-2.55%
Change (1 day)
805.26%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) Fails to deliver data
Key failure to deliver metrics for Titan Pharmaceuticals :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $0.13 M
Failures to deliver for Titan Pharmaceuticals (TTNP) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Titan Pharmaceuticals (TTNP) - since 2020
Volume in USD (price x number of shares), data since 2020Titan Pharmaceuticals (TTNP) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.02 M | -85.14% |
| 2023 | $0.16 M | -88.01% |
| 2022 | $1.38 M | -78.77% |
| 2021 | $6.51 M | -12.79% |
| 2020 | $7.47 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $30.58 M | $84.43 M | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | $0.03 M | $1.47 M | 🇺🇸 USA |
 Repligen
RGEN | $8.48 M | $0.10 B | 🇺🇸 USA |
 MediciNova MNOV | $0 M | $0.02 M | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.74 M | $3.75 M | 🇺🇸 USA |